NeuroMetrix to Present at H.C.Wainwright & Co 20th Annual Global Investment Conference in New York City

WALTHAM, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) reported that the time previously announced for its presentation at the H.C.Wainwright 20^th Annual Global Investment Conference has been shifted to 10:00 am Eastern time on Thursday September 6, 2018. A live audio webcast will be available on the investor relations section of the corporate website, www.NeuroMetrix.com. This webcast will be archived after the live event.

About 

NeuroMetrix is an innovation driven healthcare company combining neurostimulation and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company's lead product is Quell^®, an over-the-counter wearable therapeutic device for chronic pain. The company also markets DPNCheck^®, a rapid point-of-care test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. For more information, please visit NeuroMetrix.com.

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
Neurometrix.ir@neurometrix.com

Source: NeuroMetrix, Inc.

Source: NeuroMetrix, Inc.